Every Patient Deserves
Complete Evidence
Genomenon structures the biomedical literature into the real-world evidence precision medicine programs and molecular labs need.
More Patients. Expanded Labels. Confident Diagnoses.
The Evidence Already Exists. Getting to It Is the Hard Part.
The evidence to recognize the disease, classify the genetic variant, and reach the patient is already in the publsihed biomedical literature. The challenge is finding it.
Across 11.2 million full-text articles and 3.7 million supplemental datasets, the citation that would change the decision in front of your team is buried in a paper standard tools can't read deeply enough.
When the evidence stays hidden, the cost lands on patients:
- For drug development teams: Genetic variants are left out of the label. Patient populations look smaller than they are. Regulatory files are built on the evidence that was easy to find, not the complete evidence your label demands.
- For molecular labs: A VUS that should have been classified. Case sign-outs stall, get sent for review, or remain unanswered. Diagnoses arrive later than the right evidence would have otherwise allowed.
What We Offer
Software
Explore Genomenon's platforms for germline and somatic variant interpretation
Mastermind Genomic Intelligence Platform
Access actionable insights from genomic literature on more than 27 million variants, as well as curated germline variant content to aid clinical decision making.
Cancer Knowledgebase (CKB)
Genomenon's Cancer Knowledgebase is used to interpret cancer variants, connecting them to therapies and clinical trials.
Services
Genomenon's expert team of genetic scientists provides tailored consulting services to support your genomic projects. From custom variant analysis to clinical trial support and regulatory guidance, we ensure you have the expert insights needed for your specific genomic challenges.
Data
Gain access to Genomenon's expansive, constantly updated database of curated genomic information. This resource offers a wealth of gene-disease associations and variant data, whether indexed or curated, delivered via an API or flat files for direct integration into your tertiary analytic platform.
Trusted by Industry Leaders Including
"Genomenon’s innovative approach to leveraging literature for real-world evidence significantly enhanced our understanding of ENPP1 Deficiency."
Catherine Nester
Senior Vice President, HCP and Patient Engagement at Inozyme Pharma
"By partnering with Genomenon, we are helping to close critical knowledge gaps, accelerate accurate diagnosis, and support the global research community in their efforts to bring hope and new possibilities to those affected by TK2d."
Sarah Chang, Ph.D.
Medical Strategy Lead at UCB
"CKB enables comprehensive and reliable interpretation of any genomic test in a fully automated setting. We can rely on never missing relevant variants."
Korneel Duyvesteyn
Development lead at Hartwig Medical Foundation
Driving Insights and Discovery across Clinical Diagnostics and Precision Therapeutics
Never Miss a
Diagnosis
Genomenon accelerates variant interpretation and increases your diagnostic yield with rapid genomic literature search and comprehensive genomic insights.
Inform Your Drug Program
Partner with Genomenon to gain rapid, real-world evidence insights that de-risk your precision medicine program from discovery to commercialization, supporting your genetic research.
